S&P 500
(0.03%) 5 470.68 points
Dow Jones
(0.00%) 39 111 points
Nasdaq
(0.33%) 17 777 points
Oil
(-0.48%) $80.44
Gas
(-4.50%) $2.63
Gold
(-0.85%) $2 311.00
Silver
(0.01%) $28.87
Platinum
(2.29%) $1 009.00
USD/EUR
(0.25%) $0.936
USD/NOK
(0.62%) $10.67
USD/GBP
(0.45%) $0.792
USD/RUB
(-0.27%) $87.25

Realtime updates for Nuvalent, Inc. [NUVL]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated26 Jun 2024 @ 11:52

-1.05% $ 79.53

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 11:52):
Our systems believe the stock currently is overvalued by -0.07% compare to its pairs and should correct downwards.

Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferring resistance to approved and investigational ROS1 inhibitors, which is under Phase I development; and NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, central nervous system-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under Phase I/II clinical trial...

Stats
Today's Volume 76 281
Average Volume 472 941
Market Cap 5.13B
EPS $-0.690 ( Q1 | 2024-05-09 )
Next earnings date ( $-0.760 ) 2024-08-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -32.86
(Sector) 42.63
(Industry) 24.32
ATR14 $0.117 (0.15%)
AADI -2.65%
ABCL 2.56%
ABCM 0.04%
ABEO -2.13%
ABIO -1.69%
ABOS 0.70%
ABSI 2.21%
ABUS -1.98%
ABVX -1.50%
ACAD -0.45%
ACER -17.95%
ACET -4.76%
ACGN 1.29%
ACHL -2.20%
ACHV -0.43%
ACIU -1.25%
ACLX 0.97%
ACRV -4.86%
ACST -3.58%
ACXP 1.38%
ADAG 4.64%
ADAP -3.88%
ADGI 0.87%
ADIL 0.54%
ADMA -2.41%
ADPT 1.03%
ADTX -3.47%
ADVM -2.66%
ADXN -1.60%
AEON -3.74%
AEZS -2.49%
AFMD -1.14%
AGEN -2.22%
AGIO -2.27%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -1.52%
AKRO -2.26%
AKTX 4.08%
AKUS 0.00%
ALBO 0.00%
ALDX -1.50%
ALEC -0.46%
ALGS -0.22%
ALKS 0.00%
ALLK -8.51%
ALLO -4.58%
ALLR -3.37%
ALNA 3.16%
ALNY 2.02%
ALPN 0.02%
ALPX 0.00%
ALRN 0.33%
ALT -9.24%
ALVR 2.73%
ALXN 0.00%
ALXO -11.34%
ALZN 1.97%
AMRN -0.73%
AMTI -3.13%
ANAB 1.68%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX -0.98%
ANPC -3.15%
APGE -0.56%
APGN 8.48%
APGNW 30.65%
APLM -6.44%
APLS 0.94%
APLT -3.49%
APM 4.20%
APOP 0.38%
APRE 0.60%
APTO 6.12%
APTX 3.17%
APVO 0.18%
ARAV -13.39%
ARCT -4.09%
ARDS -14.23%
ARDX -0.08%
ARGX -1.03%
ARNA 0.00%
ARPO -0.90%
ARQT -1.15%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.40%
ARWR -1.15%
ASLN -5.07%
ASMB -8.31%
ASND -1.43%
ATAI -1.11%
ATHA 5.48%
ATHE 0.56%
ATHX -33.50%
ATNF 0.99%
ATOS 2.43%
ATRA -3.23%
ATXI 1.93%
ATXS -0.44%
AUPH -0.81%
AURA 1.76%
AUTL -1.29%
AVBP -1.03%
AVEO 0.00%
AVIR -0.44%
AVRO -1.41%
AVTE -4.14%
AVTX -1.25%
AVXL -2.59%
AXLA 0.00%
AXSM -1.20%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 2.35%
BCAB 4.58%
BCDA -2.23%
BCDAW -41.77%
BCEL 0.00%
BCLI 5.89%
BCRX 1.81%
BCTX 8.16%
BCTXW -16.32%
BCYC 1.61%
BDRX -2.42%
BDTX -0.85%
BEAM 1.28%
BFRA -2.91%
BGNE -2.65%
BIOR -5.21%
BIVI 3.05%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -2.50%
BLTE -0.62%
BLU 0.03%
BLUE 0.78%
BMEA -11.22%
BMRN 0.51%
BNOX 4.61%
BNTC -0.42%
BNTX -1.72%
BOLD -9.26%
BOLT 0.63%
BPMC -0.86%
BPTH 1.43%
BPTS -13.47%
BRNS -0.74%
BRTX -3.60%
BTAI 30.77%
BTTX 53.33%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.39%
CABA 1.31%
CADL -1.06%
CALA 0.00%
CALC -1.77%
CALT -1.14%
CAPR -2.80%
CARA 0.72%
CARM 13.92%
CASI -1.65%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -5.39%
CCCC -5.41%
CCXI 0.00%
CDAK 0.00%
CDIO -2.20%
CDIOW 24.00%
CDMO -2.82%
CDMOP 0.04%
CDT -11.90%
CDTTW -39.60%
CDTX -1.31%
CDXC 0.41%
CDXS 7.38%
CELC -3.76%
CELU -0.67%
CELUW 11.80%
CERC -1.68%
CERE -1.21%
CERO -3.40%
CEROW -22.75%
CFRX -27.95%
CGEM -2.37%
CGEN -3.31%
CGON -0.75%
CGTX -4.55%
CHMA -6.00%
CHRS 0.63%
CINC 0.00%
CING -0.24%
CINGW 34.95%
CKPT -2.42%
CLBS -16.75%
CLDX -1.76%
CLGN 0.34%
CLLS -4.15%
CLNN 2.44%
CLNNW 0.00%
CLRB 8.15%
CLSD 0.00%
CLSN -0.68%
CLVS 0.00%
CMMB -0.98%
CMND 2.42%
CMPI 0.00%
CMPX -5.50%
CMRA 0.00%
CMRAW 33.33%
CMRX -3.04%
CNCE 0.00%
CNSP -35.94%
CNST 0.00%
CNTA -0.34%
CNTB 0.00%
CNTX -6.85%
COCP -2.00%
COEPW 32.45%
COGT -2.16%
CORT 2.19%
COYA -1.46%
CPRX -0.79%
CRBP -2.64%
CRBU -4.27%
CRDF -0.89%
CRGX 0.71%
CRIS -1.72%
CRNX -5.86%
CRSP 1.35%
CRTX 2.63%
CRVO -2.50%
CRVS 1.80%
CSBR -1.59%
CTCX -1.60%
CTIC 0.06%
CTMX -3.31%
CTNM -1.37%
CTXR 1.08%
CUE 5.17%
CVAC -1.69%
CVKD -4.57%
CWBR 2.80%
CYAD -12.96%
CYCC 8.18%
CYCCP 5.49%
CYCN 0.43%
CYT -2.27%
CYTK -1.93%
CYTO -2.12%
DARE 5.14%
DAWN 0.75%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 27.83%
DNLI -0.94%
DNTH -8.88%
DOMH -1.58%
DRMA -1.10%
DRMAW -1.25%
DRNA 0.00%
DRTS 3.51%
DRTSW 0.00%
DRUG 0.95%
DSGN -2.56%
DTIL 1.16%
DYAI 10.32%
EARS -1.77%
EDIT -2.62%
EDSA 3.19%
EFTR 4.32%
EFTRW -51.85%
EIGR -9.21%
ELAB -1.00%
ELDN 7.98%
ELEV -5.81%
ELOX 7.69%
ELTX -0.88%
ELVN -4.26%
ELYM 2.39%
ENGN -5.12%
ENGNW 0.00%
ENLV 2.54%
ENOB 1.79%
ENSC 3.23%
ENTA -0.04%
ENTO -2.42%
ENTX 1.60%
ENVB 1.42%
EPIX -0.31%
EPRX -2.97%
EPZM 0.00%
EQ 0.32%
EQRX -2.09%
EQRXW 0.00%
ERAS -0.72%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 87.05%
ETNB -0.13%
ETON 2.13%
ETTX 0.00%
EVAX -2.14%
EVGN 3.97%
EVLO 0.00%
EWTX 0.06%
EXAI -0.47%
EXEL -0.22%
EYEG -0.69%
EYEN 0.95%
EYPT 0.97%
FATE -7.53%
FBIO 0.89%
FBIOP 0.92%
FBLG -13.90%
FBRX -0.04%
FDMT -3.36%
FENC -1.29%
FGEN -4.29%
FHTX 3.46%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.28%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE 0.09%
FULC -3.51%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.28%
GANX -1.55%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -3.97%
GHRS -2.13%
GLMD -5.09%
GLPG -2.26%
GLSI 1.41%
GLTO -0.57%
GLUE -2.51%
GLYC -10.12%
GMAB -0.54%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -3.39%
GNLX 1.33%
GNPX 0.98%
GNTA 3.94%
GOSS -10.56%
GOVX 2.75%
GOVXW -49.04%
GPCR -6.93%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -0.06%
GRTX 2.57%
GTHX 0.46%
GUTS -4.97%
GXGXW 41.67%
GYRE -5.07%
HALO -1.18%
HARP 0.09%
HCWB -3.75%
HEPA -3.64%
HGEN -84.62%
HILS 5.66%
HLVX -0.23%
HOOK -0.68%
HOTH -2.70%
HOWL -1.50%
HRMY 0.86%
HRTX 4.10%
HSTO 0.00%
HUMA 0.61%
HUMAW -0.01%
IBRX -3.54%
ICCC 0.22%
ICPT 0.21%
ICU 17.20%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -1.55%
IFRX -1.80%
IGMS 1.19%
IKNA 1.19%
IKT 1.42%
IMAB 1.74%
IMCR -3.19%
IMGN 0.02%
IMGO 0.00%
IMMP 5.70%
IMMX -6.47%
IMNM -1.08%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX -0.35%
IMTX -1.67%
IMTXW 6.00%
IMUX 1.56%
IMV 0.00%
IMVT -3.66%
INAB -0.01%
INBX 1.13%
INCY -0.90%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM 1.90%
INMB 2.53%
INO -1.69%
INSM -0.95%
INTS -2.75%
INVA 0.50%
INZY 1.14%
IOBT -11.02%
IONS 0.16%
IOVA -2.02%
IPA 0.00%
IPHA 5.58%
IPSC -1.37%
IRON -2.45%
ISEE 0.38%
ITOS -1.27%
ITRM 1.67%
IVA 6.96%
IVVD -2.07%
JAGX 1.57%
JANX -3.57%
JAZZ -0.56%
JNCE 0.00%
JSPR -6.20%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.54%
KALV -1.34%
KDNY 0.22%
KMPH -0.34%
KNSA -2.45%
KNTE -0.38%
KOD -6.72%
KPRX 0.96%
KPTI -2.29%
KRBP -10.00%
KRON 1.05%
KROS -0.72%
KRRO -7.66%
KRTX 0.03%
KRYS -0.91%
KTRA 15.65%
KTTA 8.16%
KTTAW 0.92%
KURA -1.12%
KYMR -2.47%
KYTX -4.01%
KZIA 2.65%
KZR -0.93%
LABP 0.57%
LBPH -1.75%
LBPS 0.00%
LBPSW 14.81%
LEGN 2.09%
LENZ -3.67%
LEXX 0.76%
LEXXW -14.63%
LGND -1.33%
LGNDV 0.00%
LGVN -9.84%
LIAN -8.28%
LIFE 2.70%
LIPO -11.13%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 1.65%
LPCN -2.94%
LPTX -1.10%
LQDA -0.33%
LRMR -2.27%
LSTA -4.06%
LTRN 1.37%
LUMO -1.32%
LVTX -1.03%
LXEO -4.21%
LXRX -1.47%
LYEL -33.42%
LYRA 0.93%
MACK 0.10%
MBIO -11.12%
MBRX -2.57%
MCRB 1.83%
MDGL -2.75%
MDNA -13.16%
MDWD -0.27%
MDXG -2.43%
MEIP -0.13%
MESO -2.08%
MGNX -3.21%
MGTA -7.74%
MGTX -3.33%
MGX -4.83%
MIRM -1.52%
MIRO 0.59%
MIST 0.77%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX -0.98%
MLYS -6.66%
MNKD -0.48%
MNMD 0.28%
MNOV 2.11%
MNPR -5.01%
MOLN 1.79%
MOR 1.20%
MORF -2.83%
MREO -2.85%
MRKR 2.57%
MRNA -5.23%
MRNS -4.04%
MRSN -1.90%
MRTX -0.17%
MRUS -0.05%
MRVI -1.53%
MTCR -1.29%
MTEM 4.95%
MTP -18.50%
MURA -0.93%
MYMD 5.41%
NAMS 1.57%
NAMSW 0.43%
NAUT 1.77%
NBRV 0.71%
NBSE -1.56%
NBTX 8.61%
NCNA 1.45%
NERV -0.63%
NEXI 4.04%
NGM -1.28%
NGNE -1.25%
NKGN 9.17%
NKGNW 8.00%
NKTR -3.74%
NKTX -4.73%
NLSP 6.00%
NLSPW 26.67%
NMRA -0.91%
NMTR -42.97%
NOVN -24.84%
NRBO 11.50%
NRIX -0.31%
NRSN -5.12%
NRSNW 0.00%
NRXP -5.20%
NRXPW 18.33%
NRXS 4.82%
NTBL 5.06%
NTEC -12.45%
NTHI 0.00%
NTLA -5.21%
NTRBW -31.07%
NUVL -1.05%
NVAX -2.32%
NVCT 4.55%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 0.13%
OABIW -10.06%
OBIO -4.95%
OBSV 0.00%
OCEA -0.70%
OCGN 4.66%
OCS -1.00%
OCUL -1.45%
OCUP 1.31%
ODT -4.27%
OKYO 1.51%
OLMA -5.53%
OMER -0.13%
OMGA 5.39%
ONCO 4.96%
ONCR -3.08%
ONCS 31.87%
ONCT -3.05%
ONCY 0.00%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT 2.06%
ORGS 0.65%
ORIC -3.19%
ORMP 22.32%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.67%
OVID -1.44%
OYST 0.00%
PALI 2.61%
PASG -1.30%
PBLA -7.50%
PBM -8.21%
PBYI 1.35%
PCSA 0.00%
PCVX 0.23%
PDSB -4.43%
PEPG 2.56%
PGEN -1.80%
PHAR 1.51%
PHAS 0.00%
PHAT -1.36%
PHIO -0.83%
PHIOW 36.47%
PHVS -6.81%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.10%
PLUR 5.78%
PMN 0.72%
PMVP 0.00%
PNT 0.16%
PPBT -6.84%
PRAX 1.59%
PRDS 0.93%
PRLD -3.17%
PROG -3.47%
PROK -0.45%
PRQR 0.00%
PRTA -1.97%
PRTC 0.49%
PRTG -0.54%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -8.54%
PSTX -0.39%
PTCT -0.23%
PTE -0.82%
PTGX -1.01%
PTIXW -49.04%
PULM 2.60%
PXMD 0.00%
PYPD 0.07%
PYXS 1.64%
QLGN -3.64%
QNCX 5.70%
QNRX 0.37%
QSI -11.97%
QSIAW -3.13%
QTTB -2.10%
QURE -0.45%
RAIN -1.63%
RANI 6.42%
RAPT -2.92%
RARE 1.58%
RCKT -7.41%
REGN -0.27%
RENB -3.42%
REPL -2.61%
RETA 0.02%
REUN -0.89%
REVB -2.78%
REVBU 3.46%
REVBW 4.38%
RGLS -5.37%
RGNX -5.03%
RIGL -3.28%
RLAY -3.57%
RLMD 0.67%
RLYB -0.67%
RNA 0.30%
RNAC -5.94%
RNAZ -1.72%
RNXT 0.01%
ROIV -1.57%
ROIVW 4.56%
RPHM -0.31%
RPRX 0.28%
RPTX -1.76%
RUBY 2.70%
RVLP -32.05%
RVMD -0.72%
RVMDW -30.00%
RVNC 2.34%
RVPH -1.19%
RVPHW 1.62%
RXDX 0.09%
RXRX -2.70%
RYTM -5.15%
RYZB 0.02%
RZLT 2.08%
SABS -1.37%
SABSW -11.81%
SAGE 1.65%
SANA -2.78%
SAVA -0.36%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 5.50%
SCPH 2.40%
SCPS 0.00%
SEEL -3.94%
SEER 1.18%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO 0.56%
SGMT -2.18%
SGTX -2.56%
SIOX 22.63%
SLDB -6.55%
SLGL 2.97%
SLN -4.40%
SLNO -3.76%
SLRX 6.07%
SLS -1.72%
SMMT -2.25%
SNDX 1.59%
SNGX -4.91%
SNPX -3.84%
SONN -1.08%
SPPI -0.49%
SPRB 0.91%
SPRC -2.75%
SPRO 0.05%
SRNE -34.00%
SRPT -0.80%
SRRA 0.00%
SRRK -1.43%
SRZN -2.45%
STAB 0.00%
STOK -4.09%
STRO -2.84%
STSA 0.00%
STTK 0.14%
SURF -0.93%
SVRA -5.13%
SWTX 0.49%
SYBX -1.29%
SYRS -1.03%
TALS -0.73%
TARA -7.14%
TARS 0.10%
TBPH 0.48%
TCBP 2.48%
TCDA 0.00%
TCON 2.46%
TCRR 0.00%
TCRT 1.59%
TCRX 0.16%
TECH -0.06%
TENX 1.91%
TERN -7.59%
TFFP -5.33%
TGTX -2.87%
THRX 0.12%
TIL -1.09%
TLC 0.00%
TLSA -2.59%
TNGX -2.48%
TNXP -5.55%
TNYA -4.37%
TPST 2.91%
TRDA -4.64%
TRVI 2.30%
TRVN 2.97%
TSHA -22.11%
TSVT -3.20%
TTNP -7.66%
TVTX 1.26%
TYRA -6.98%
UBX -2.51%
UNCY -3.74%
URGN -1.52%
UTHR -0.28%
VACC 11.36%
VALN -2.89%
VAXX 80.63%
VBIV 0.78%
VBLT -8.77%
VCEL 0.21%
VCNX 10.35%
VCYT -0.70%
VERA -3.39%
VERU 0.05%
VERV -2.68%
VIGL 6.32%
VINC 2.96%
VIR 1.14%
VIRI -1.61%
VIRX 2.40%
VKTX -1.21%
VLON -13.04%
VNDA -2.52%
VOR -2.02%
VRCA 0.14%
VRDN -4.15%
VRNA -1.73%
VRPX 0.38%
VRTX 0.44%
VSTM -0.68%
VTGN -1.05%
VTVT -2.97%
VTYX -1.29%
VXRT -2.75%
VYGR -0.45%
VYNE -4.62%
VYNT 7.78%
WINT -3.24%
WVE -4.41%
XBIO 0.93%
XBIT -0.42%
XCUR 3.58%
XENE -2.44%
XERS 2.39%
XFOR 2.52%
XLO 4.43%
XLRN 0.00%
XNCR 0.78%
XOMA -2.14%
XOMAO 0.36%
XOMAP -0.82%
XRTX -8.00%
YMAB -1.63%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.75%
ZNTL -0.36%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-14 Conley Emily Sell 5 000 Stock Option (Right to Buy)
2024-06-14 Conley Emily Buy 5 000 Class A Common Stock
2024-06-14 Conley Emily Sell 4 777 Class A Common Stock
2024-06-14 Conley Emily Sell 223 Class A Common Stock
2024-06-12 Flynn James E Buy 3 789 Stock Option (Right to Buy)
INSIDER POWER
-80.71
Last 100 transactions
Buy: 133 880 | Sell: 1 327 400
Correlation (AI algo v.1.1b): Overvalued: -0.07% $79.59 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.39 (neutral)
Short: 0.56 (weak)
Signal:(78.075) Neutral

Nuvalent, Inc. Correlation

10 Most Positive Correlations
HURC0.868
BIMI0.866
BRZE0.863
CRBU0.861
ASUR0.861
GRPN0.861
SPRB0.859
REE0.854
ATER0.847
PDSB0.846
10 Most Negative Correlations
GLNG-0.88
EH-0.876
PAAS-0.862
CWBC-0.861
RING-0.858
HSON-0.852
CENX-0.844
CRIS-0.835
USEG-0.832
AMRK-0.824

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nuvalent, Inc. Correlation - Currency/Commodity

The country flag -0.25
( neutral )
The country flag -0.37
( neutral )
The country flag 0.00
( neutral )
The country flag -0.48
( neutral )
The country flag 0.02
( neutral )
The country flag -0.16
( neutral )

Nuvalent, Inc. Financials

Annual 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-2.17
FY 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-2.17
FY 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-1.480
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-2.87

Financial Reports:

No articles found.

Nuvalent, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Nuvalent, Inc.

Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferring resistance to approved and investigational ROS1 inhibitors, which is under Phase I development; and NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, central nervous system-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under Phase I/II clinical trial. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 2.2182199954987 seconds
Number of API calls: 3
Number of DB calls: 9